快樂小藥師
- May 17 Tue 2011 07:21
SIRS→sepsis→severe sepsis→septic shock 全身性發炎症候群→敗血症→嚴重敗血症→敗血性休克
- May 16 Mon 2011 05:12
Bacteremia 菌血症
Bacteremia is the presence of bacteria in the bloodstream. It can occur spontaneously, during certain tissue infections, with use of indwelling GU or IV catheters, or after dental, GI, GU, wound-care, or other procedures. Bacteremia may cause metastatic infections, including endocarditis, especially in patients with valvular heart abnormalities. Transient bacteremia is often asymptomatic but may cause fever. Development of other symptoms usually suggests more serious infection, such as sepsis or septic shock.
- May 15 Sun 2011 08:56
overview of sepsis 認識敗血症
- May 14 Sat 2011 18:37
血汗醫院誰的錯?
血汗醫院並不是一個問題,他是一個現象,就像是骰子一樣,他有六面,血汗醫院只是其中一面,其他的還有藥物浪費,醫療崩壞,醫藥分業,醫藥養成教育等等的另外幾個面相,但是這些,都不是問題的核心..........
- May 14 Sat 2011 05:23
[WebMD]紅酒、鹽與你的心臟:關係一團混亂
根據美國心臟協會(AHA)的一項新調查結果,多數美國人相信喝紅酒有益心臟,但是可能未充分暸解飲用上限,飲酒過量可能會導致嚴重的健康問題;此外,調查顯示,多數人也誤認為海鹽是替代食鹽不錯的低鈉品項。
- May 13 Fri 2011 05:02
[急診]打嗝(Hiccup)的急診處理
- May 12 Thu 2011 05:31
[急診]腹瀉(diarrhea)處理
- May 11 Wed 2011 05:06
繼續認識輻射
- May 10 Tue 2011 06:52
[圖解藥理學]12抗生素機轉 11
最近又更新了一些:
- May 09 Mon 2011 08:55
活性炭
- May 08 Sun 2011 06:00
neostigmine與睫狀肌
這件事情會成為問題,我也覺得很意外,不過對於現在很擅長使用網路訊息的實習生來說,卻存在著這樣的問題:
如果看眼科時,醫師判斷你眼睛疲勞,會給你neostigmine,讓你放鬆睫狀肌。
- May 07 Sat 2011 07:49
[急診]Acetaminophen中毒與處置
看到這標題,你大概會想:這還需要講?
確實,之前也跟大家提過很多次了:
N acetylcysteine對Acetaminophen的中毒治療
Acetaminophen與Acetylcysteine併用?
- May 06 Fri 2011 05:58
Office 2011 中文版正式上市
期待以久,微軟果然沒有框我們
- May 05 Thu 2011 06:03
[Medscape]Inhaled Steroids Lower Pneumonia Mortality in COPD Patients
For patients with chronic obstructive pulmonary disease (COPD), prior use of inhaled corticosteroids (ICS) is associated with a lower risk for short-term mortality and lower use of mechanical ventilation after hospitalization for pneumonia, according to the results of a retrospective database analysis reported online April 15 in the American Journal of Respiratory and Critical Care Medicine.
- May 04 Wed 2011 08:58
FDA Approves New Drug (linagliptin) for Type 2 Diabetes
The US Food and Drug Administration (FDA) today approved linagliptin (Tradjenta, Eli Lilly Co and Boehringer Ingelheim Pharmaceuticals) for improving blood glucose control in adults with type 2 diabetes, either as a stand-alone or in combination with other therapies.
- May 03 Tue 2011 05:27
2011年5月新藥小簡介
今年已經過五個月了,讓我們來回顧一下,前一個月多了哪些新東西吧:
- May 02 Mon 2011 05:02
[吃喝玩樂]頂級龍蝦之王~uncle george 安可喬治
- May 01 Sun 2011 06:00
[WebMD]兒童濕疹用皮質類固醇不會傷害皮膚
刊載在小兒皮膚學(Pediatric Dermatology)的研究顯示,若是正確使用類固醇藥膏治療兒童濕疹,就不會傷害肌膚或是使皮膚變薄。
- Apr 30 Sat 2011 06:15
FDA Drug Safety Communication: Safety update on Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)
- Apr 29 Fri 2011 05:54
[WebMD]胰島素對於阿茲海默氏症可能有治療潛力
- Apr 28 Thu 2011 05:53
[WebMD]治療高血壓可延緩阿茲海默氏症
治療高血壓可延緩39%研究對象的阿茲海默氏症病程
- Apr 27 Wed 2011 05:44
[Medscape Nephrology]Managing ESRD: Take-Away Points From the DaVita Project
Introduction
- Apr 26 Tue 2011 06:34
[Medscape Education Clinical Briefs]Proton Pump Inhibitors Ineffective in Infants With GERD
Proton pump inhibitors (PPIs) are ineffective in reducing gastroesophageal reflux disease (GERD) symptoms in infants, and placebo-controlled trials in older children are lacking, according to the results of a systematic review reported online April 4 and will appear in the May print issue of Pediatrics.
- Apr 25 Mon 2011 05:30
[Medscape Education Clinical Briefs]First ACR Advice for Juvenile Idiopathic Arthritis Treatment (美國風濕學院對兒童型特異性關節炎的建議)
The American College of Rheumatology (ACR) discusses treatment options for juvenile idiopathic arthritis (JIA) and puts forth a set of recommendations intended to help clinicians navigate the data related to initiating and monitoring drug treatment. The recommendations appear in the April issue of Arthritis Care & Research and were endorsed by the Arthritis Foundation.
- Apr 24 Sun 2011 05:28
[FDA Approvals]Fidaxomicin Noninferior to Vancomycin for Treatment of C Difficile Infection
Compared with vancomycin, fidaxomicin (Optimer Pharmaceuticals, Inc) produces noninferior rates of clinical cure in adults with Clostridium difficile infection. In addition, for some strains, fidaxomicin is associated with a significantly lower rate of recurrence, according to the findings of a randomized trial.